P8A logo

Cordlife Group Limited Stock Price

SGX:P8A Community·S$33.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

P8A Share Price Performance

S$0.13
-0.02 (-15.48%)
S$0.13
-0.02 (-15.48%)
Price S$0.13

P8A Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
0 Rewards

Cordlife Group Limited Key Details

S$37.7m

Revenue

S$16.6m

Cost of Revenue

S$21.2m

Gross Profit

S$33.2m

Other Expenses

-S$12.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.047
56.10%
-31.95%
0%
View Full Analysis

About P8A

Founded
2001
Employees
n/a
CEO
Xiaoling Chen
WebsiteView website
www.cordlife.com

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services. The company also provides corneal lenticule banking, gut microbiome banking, and lifestyle genetic screening services for adults. In addition, it offers Moms Up, a mobile application that offers parenting resources, as well as sprouts for health, wellness, and lifestyle needs. Further, the company provides medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services. Cordlife Group Limited was incorporated in 2001 and is based in Singapore.

Recent P8A News & Updates

Recent updates

No updates